Eric Sievers
16Patents
7h-index
16Co-inventors
59Inventor score
Filing activity: Aug 9, 2006 → May 24, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7695716B2 | Methods of treating neoplastic, autoimmune and inflammatory diseases | Chemistry; Metallurgy | 73 | Active |
| US8470329B2 | Combination therapy with antibody-drug conjugates | Human Necessities | 20 | Active |
| US8263083B2 | Combination therapy with antibody-drug conjugates | Human Necessities | 19 | Active |
| US9211319B2 | Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 13 | Active |
| US9713648B2 | Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 10 | Active |
| US10098963B2 | Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 9 | Active |
| US8758758B1 | Post-relapse treatment of CD30 expressing lymphomas | Chemistry; Metallurgy | 7 | Active |
| US10722549B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 6 | Active |
| US10478469B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 5 | Active |
| US10912813B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 4 | Active |
| US10940178B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 3 | Active |
| US11077164B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 2 | Active |
| US11369658B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 1 | Active |
| US7842292B2 | Methods for treating B-cell malignancies using a TACI-Ig fusion molecule | Chemistry; Metallurgy | 1 | Active |
| US8808696B2 | Methods for the treatment and prevention of abnormal cell proliferation using TACI-fusion molecules | Chemistry; Metallurgy | 1 | Active |
| US11559558B2 | Weekly dosing regimens for anti-CD30 vc-PAB-MMAE antibody drug-conjugates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.